CISD2 and breast carcinoma: Silencing CISD1 and CISD2 or targeting breast cancer mitochondria with the mitogen derivative MAD-28 can destabilize iron-sulfur proteins, elevate mitochondrial iron accumulation, and hinder breast cancer cell growth (Bai et al., 2015).